OS-01

OS-01 (also known as OneSkin OS-01 peptide, p53-activating peptide) is a prominently researched experimental compound classified strictly within the Cosmetic Peptide framework. Operating primarily through advanced pharmacological pathways, its core mechanism of action is as follows: it proprietary 8-amino acid peptide developed by OneSkin Technologies. Activates p53-mediated clearance of senescent skin cells in the epidermis and dermis. Reduces markers of cellular senescence (p21, p16) in keratinocytes and fibroblasts, promotes renewal of the epidermal skin cell population, and reduces UV-induced DNA damage accumulation. Applied topically — NOT for injection. OneSkin has published peer-reviewed data demonstrating reversal of skin's biological age via methylation clock analysis. with an established metabolic degradation profile, In preclinical investigative trials and independent academic studies, researchers utilizing OS-01 have documented significant, quantifiable biological outcomes, primarily focusing on skin cellular age reversal, senescent skin cell clearance, photoaging repair, epidermal renewal. Typical research protocols investigate administering 0 to 0mcg via topical pathways daily (morning or evening). However, it is critically important to understand that while OS-01 demonstrates profound physiological potential in highly controlled laboratory settings, it remains classified strictly as a research chemical and has not been approved by the United States Food and Drug Administration (FDA) for human therapeutic, diagnostic, or dietary consumption. Independent chemical analysis via rigorous third-party Certificate of Analysis (COA) testing utilizing High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) remains the industry gold standard for verifying its base elemental stability when reconstituted appropriately in sterile bacteriostatic water.